Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Breast"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 41-60 z 890170
Tytuł:
Benign Vascular Lesions of the Breast: A Clinical, Radiographic, and Pathologic Review.
Autorzy:
Braun A; Rush University Medical Center, Department of Pathology, Chicago, IL, USA.
Solari M; Rush University Medical Center, Department of Pathology, Chicago, IL, USA.; Rush University Medical Center, Department of Radiology, Chicago, IL, USA.
Gattuso P; Rush University Medical Center, Department of Pathology, Chicago, IL, USA.
Agarwal I; Rush University Medical Center, Department of Radiology, Chicago, IL, USA.; Northwestern University, McGaw Medical Center, Department of Pathology, Chicago, IL, USA.
Pokaż więcej
Źródło:
International journal of surgical pathology [Int J Surg Pathol] 2023 Dec; Vol. 31 (8), pp. 1437-1448. Date of Electronic Publication: 2023 Apr 09.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Hemangioma*/diagnostic imaging
Hemangioma*/pathology
Angiomatosis*/diagnostic imaging
Angiomatosis*/pathology
Breast Neoplasms*/diagnostic imaging
Breast Neoplasms*/pathology
Humans ; Female ; Neoplasm Recurrence, Local/pathology ; Breast/diagnostic imaging ; Breast/pathology ; Biopsy, Large-Core Needle
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Protocol for a pragmatic stepped wedge cluster randomized clinical trial testing behavioral economic implementation strategies to increase supplemental breast MRI screening among patients with extremely dense breasts.
Autorzy:
McCarthy AM; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. .; Penn Center for Cancer Care Innovation, Abramson Cancer Center, Penn Medicine, Philadelphia, PA, USA. .; Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Blockley Hall, 423 Guardian Drive, Philadelphia, PA, 19104, USA. .
Fernandez Perez C; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Beidas RS; Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Bekelman JE; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Penn Center for Cancer Care Innovation, Abramson Cancer Center, Penn Medicine, Philadelphia, PA, USA.
Blumenthal D; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Center for Interdisciplinary Research On Nicotine Addiction, University of Pennsylvania, Philadelphia, PA, USA.
Mack E; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Bauer AM; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Center for Interdisciplinary Research On Nicotine Addiction, University of Pennsylvania, Philadelphia, PA, USA.
Ehsan S; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Conant EF; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Wheeler BC; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Guerra CE; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Penn Center for Cancer Care Innovation, Abramson Cancer Center, Penn Medicine, Philadelphia, PA, USA.
Nunes LW; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Gabriel P; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Penn Center for Cancer Care Innovation, Abramson Cancer Center, Penn Medicine, Philadelphia, PA, USA.
Doucette A; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Wileyto EP; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Blockley Hall, 423 Guardian Drive, Philadelphia, PA, 19104, USA.; Center for Interdisciplinary Research On Nicotine Addiction, University of Pennsylvania, Philadelphia, PA, USA.
Buttenheim AM; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Penn Center for Cancer Care Innovation, Abramson Cancer Center, Penn Medicine, Philadelphia, PA, USA.; School of Nursing, University of Pennsylvania, Philadelphia, PA, USA.
Asch DA; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Penn Center for Cancer Care Innovation, Abramson Cancer Center, Penn Medicine, Philadelphia, PA, USA.
Rendle KA; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Penn Center for Cancer Care Innovation, Abramson Cancer Center, Penn Medicine, Philadelphia, PA, USA.; Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Blockley Hall, 423 Guardian Drive, Philadelphia, PA, 19104, USA.
Shelton RC; Mailman School of Public Health, Columbia University, New York, NY, USA.
Fayanju OM; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Penn Center for Cancer Care Innovation, Abramson Cancer Center, Penn Medicine, Philadelphia, PA, USA.
Ware S; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Center for Interdisciplinary Research On Nicotine Addiction, University of Pennsylvania, Philadelphia, PA, USA.
Plag M; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Hyland S; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Gionta T; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Shulman LN; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Penn Center for Cancer Care Innovation, Abramson Cancer Center, Penn Medicine, Philadelphia, PA, USA.
Schnoll R; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Penn Center for Cancer Care Innovation, Abramson Cancer Center, Penn Medicine, Philadelphia, PA, USA.; Center for Interdisciplinary Research On Nicotine Addiction, University of Pennsylvania, Philadelphia, PA, USA.
Pokaż więcej
Źródło:
Implementation science : IS [Implement Sci] 2023 Nov 24; Vol. 18 (1), pp. 65. Date of Electronic Publication: 2023 Nov 24.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Breast Neoplasms*/diagnostic imaging
Breast Neoplasms*/prevention & control
Humans ; Female ; Breast Density ; Mammography ; Economics, Behavioral ; Magnetic Resonance Imaging ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Comparison of adverse events in partial- or whole breast radiotherapy: investigation of cosmesis, toxicities and quality of life in a meta-analysis of randomized trials.
Autorzy:
Haussmann J; Department of Radiation Oncology, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany. .
Budach W; Department of Radiation Oncology, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany.
Corradini S; Department of Radiation Oncology, Ludwig Maximillian University, Munich, Germany.
Krug D; Department of Radiation Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.
Jazmati D; Department of Radiation Oncology, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany.
Tamaskovics B; Department of Radiation Oncology, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany.
Bölke E; Department of Radiation Oncology, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany.
Pedotoa A; Department of Anesthesiology, Memorial Sloan Kettering Cancer Center, New York City, New York, USA.
Kammers K; Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, USA.
Matuschek C; Department of Radiation Oncology, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany.
Pokaż więcej
Źródło:
Radiation oncology (London, England) [Radiat Oncol] 2023 Nov 02; Vol. 18 (1), pp. 181. Date of Electronic Publication: 2023 Nov 02.
Typ publikacji:
Systematic Review; Meta-Analysis; Journal Article
MeSH Terms:
Quality of Life*
Breast Neoplasms*/radiotherapy
Breast Neoplasms*/surgery
Humans ; Female ; Treatment Outcome ; Randomized Controlled Trials as Topic ; Breast ; Mastectomy, Segmental
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Sexual function index adaptation for breast cancer patients (FSFI-BC)- translation and psychometric properties of Persian version.
Autorzy:
Masjoudi M; Midwifery Department, Rasht Branch, Islamic Azad University, Rasht, Iran.
Keshavarz Z; Midwifery Department, Shahid Beheshti University of Medical Sciences (SBMU), Vali-Asr Ave, Niayesh Cross Road, Niayesh Complex, Tehran, 1985717443, Iran. .
Akbari ME; Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Kashani FL; Islamic Azad University, Roudehen branch, Tehran, Iran.
Nasiri M; Basic Science Department, Shahid Beheshti University of medical sciences, Tehran, Iran.
Mirzaei HR; Department of Radiotherapy, School of Medicine, Shohada-e-Tajrish Hospital Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Pokaż więcej
Źródło:
BMC women's health [BMC Womens Health] 2024 Jan 24; Vol. 24 (1), pp. 66. Date of Electronic Publication: 2024 Jan 24.
Typ publikacji:
Journal Article
MeSH Terms:
Breast Neoplasms*/complications
Breast Neoplasms*/diagnosis
Cancer Survivors*
Humans ; Female ; Psychometrics ; Reproducibility of Results ; Breast
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Adjuvant medial versus entire supraclavicular lymph node irradiation in high-risk early breast cancer (SUCLANODE): a protocol for a multicenter, randomized, open-label, phase 3 trial.
Autorzy:
Zhang L; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, 270 Dong-An Road, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.; Shanghai Key Laboratory of Radiation Oncology, Shanghai, 200032, China.
Mei X; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, 270 Dong-An Road, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.; Shanghai Key Laboratory of Radiation Oncology, Shanghai, 200032, China.
Hu Z; Department of Radiation Oncology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230001, China.
Yu B; Department of Radiotherapy, the Affiliated Jiangyin Hospital of Nantong University, Jiangyin, 214400, China.
Zhang C; Department of Radiation Oncology, The First Hospital of Quanzhou Affiliated to Fujian Medical University, Fuzhou, China.
Li Y; Department of Oncology, Guizhou Provincial People's Hospital, Guiyang, China.
Liu K; Department of Radiation Oncology, The Affiliated Lihuili Hospital of Ningbo University, Ningbo, Zhejiang, 315040, China.
Ma X; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, 270 Dong-An Road, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.; Shanghai Key Laboratory of Radiation Oncology, Shanghai, 200032, China.
Ma J; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, 270 Dong-An Road, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.; Shanghai Key Laboratory of Radiation Oncology, Shanghai, 200032, China.
Chen X; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, 270 Dong-An Road, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.; Shanghai Key Laboratory of Radiation Oncology, Shanghai, 200032, China.
Meng J; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, 270 Dong-An Road, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.; Shanghai Key Laboratory of Radiation Oncology, Shanghai, 200032, China.
Shi W; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, 270 Dong-An Road, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.; Shanghai Key Laboratory of Radiation Oncology, Shanghai, 200032, China.
Wang X; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, 270 Dong-An Road, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.; Shanghai Key Laboratory of Radiation Oncology, Shanghai, 200032, China.
Mo M; Department of Cancer Prevention & Clinical Statistics Center, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
Shao Z; Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.; Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
Zhang Z; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, 270 Dong-An Road, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.; Shanghai Key Laboratory of Radiation Oncology, Shanghai, 200032, China.
Yu X; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, 270 Dong-An Road, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.; Shanghai Key Laboratory of Radiation Oncology, Shanghai, 200032, China.
Guo X; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, 270 Dong-An Road, Shanghai, 200032, China. .; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China. .; Shanghai Key Laboratory of Radiation Oncology, Shanghai, 200032, China. .
Yang Z; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, 270 Dong-An Road, Shanghai, 200032, China. .; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China. .; Shanghai Key Laboratory of Radiation Oncology, Shanghai, 200032, China. .; Department of Medical Oncology, Kashgar Prefecture Second People ' s Hospital, Xinjiang Uyghur Autonomous Region, Kashgar, 844000, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Jan 09; Vol. 24 (1), pp. 49. Date of Electronic Publication: 2024 Jan 09.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Breast Neoplasms*/radiotherapy
Breast Neoplasms*/surgery
Humans ; Female ; Mastectomy ; Adjuvants, Immunologic ; Lymph Nodes ; Breast ; Randomized Controlled Trials as Topic ; Multicenter Studies as Topic ; Clinical Trials, Phase III as Topic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Multi-MicroRNA Analysis Can Improve the Diagnostic Performance of Mammography in Determining Breast Cancer Risk.
Autorzy:
Song JE; Department of Family Medicine, Kyungpook National University Chilgok Hospital, 807 Hoguk-ro, Buk-gu, Daegu 41404, Republic of Korea.
Jang JY; BIOINFRA Life Science Inc., Jongno-gu, Seoul 03127, Republic of Korea.
Kang KN; BIOINFRA Life Science Inc., Jongno-gu, Seoul 03127, Republic of Korea.
Jung JS; BIOINFRA Life Science Inc., Jongno-gu, Seoul 03127, Republic of Korea.
Kim CW; BIOINFRA Life Science Inc., Jongno-gu, Seoul 03127, Republic of Korea.
Kim AS; Department of Family Medicine, Kyungpook National University Chilgok Hospital, 807 Hoguk-ro, Buk-gu, Daegu 41404, Republic of Korea.
Pokaż więcej
Źródło:
The breast journal [Breast J] 2023 Dec 27; Vol. 2023, pp. 9117047. Date of Electronic Publication: 2023 Dec 27 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Breast Neoplasms*/diagnostic imaging
Breast Neoplasms*/genetics
MicroRNAs*/genetics
Fibrocystic Breast Disease*
Female ; Humans ; Mammography/methods ; Breast ; Biomarkers
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The Role of Transcription Factors in the Loss of Inter-Chromosomal Co-Expression for Breast Cancer Subtypes.
Autorzy:
Trujillo-Ortíz R; Computational Genomics Division, Instituto Nacional de Medicina Genómica, Mexico City 14610, Mexico.
Espinal-Enríquez J; Computational Genomics Division, Instituto Nacional de Medicina Genómica, Mexico City 14610, Mexico.; Center for Complexity Sciences, Universidad Nacional Autónoma de México, Mexico City 01010, Mexico.
Hernández-Lemus E; Computational Genomics Division, Instituto Nacional de Medicina Genómica, Mexico City 14610, Mexico.; Center for Complexity Sciences, Universidad Nacional Autónoma de México, Mexico City 01010, Mexico.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Dec 16; Vol. 24 (24). Date of Electronic Publication: 2023 Dec 16.
Typ publikacji:
Journal Article
MeSH Terms:
Breast Neoplasms*/genetics
Humans ; Female ; Transcription Factors/genetics ; Breast ; Chromosomes ; Gene Expression Regulation, Neoplastic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Promoter hypermethylation of RARB and GSTP1 genes in plasma cell-free DNA as breast cancer biomarkers in Peruvian women.
Autorzy:
Danos P; Centro de Genética y Biología Molecular, Universidad de San Martín de Porres, Lima, Peru.
Giannoni-Luza S; Centro de Genética y Biología Molecular, Universidad de San Martín de Porres, Lima, Peru.
Murillo Carrasco AG; Centro de Genética y Biología Molecular, Universidad de San Martín de Porres, Lima, Peru.
Acosta O; Facultad de Medicina Humana, Universidad de San Martín de Porres, Chiclayo, Peru.; Facultad de Farmacia y Bioquímica, Universidad Nacional Mayor de San Marcos, Lima, Peru.
Guevara-Fujita ML; Centro de Genética y Biología Molecular, Universidad de San Martín de Porres, Lima, Peru.
Cotrina Concha JM; Instituto Nacional de Enfermedades Neoplásicas (INEN), Lima, Peru.
Guerra Miller H; Instituto Nacional de Enfermedades Neoplásicas (INEN), Lima, Peru.
Pinto Oblitas J; Oncosalud-Auna, Lima, Peru.
Aguilar Cartagena A; Oncosalud-Auna, Lima, Peru.
Araujo JM; Oncosalud-Auna, Lima, Peru.
Fujita R; Centro de Genética y Biología Molecular, Universidad de San Martín de Porres, Lima, Peru.
Buleje Sono JL; Centro de Genética y Biología Molecular, Universidad de San Martín de Porres, Lima, Peru.
Pokaż więcej
Źródło:
Molecular genetics & genomic medicine [Mol Genet Genomic Med] 2023 Dec; Vol. 11 (12), pp. e2260. Date of Electronic Publication: 2023 Aug 07.
Typ publikacji:
Journal Article
MeSH Terms:
Breast Neoplasms*/genetics
Breast Neoplasms*/pathology
Female ; Humans ; Middle Aged ; Biomarkers, Tumor/genetics ; Breast/pathology ; Case-Control Studies ; DNA Methylation ; Glutathione S-Transferase pi/genetics ; Peru
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Evaluation of tumor-infiltrating lymphocytes and mammographic density as predictors of response to neoadjuvant systemic therapy in breast cancer.
Autorzy:
Landén AH; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Chin K; Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Kovács A; Department of Clinical Pathology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Holmberg E; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Molnar E; Department of Radiology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Stenmark Tullberg A; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Wärnberg F; Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Karlsson P; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Pokaż więcej
Źródło:
Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2023 Dec; Vol. 62 (12), pp. 1862-1872. Date of Electronic Publication: 2023 Nov 25.
Typ publikacji:
Journal Article
MeSH Terms:
Breast Neoplasms*/diagnostic imaging
Breast Neoplasms*/drug therapy
Breast Neoplasms*/etiology
Carcinoma*/pathology
Humans ; Female ; Lymphocytes, Tumor-Infiltrating/pathology ; Breast Density ; Neoadjuvant Therapy/methods ; Prognosis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Imaging-proteomic analysis for prediction of neoadjuvant chemotherapy responses in patients with breast cancer.
Autorzy:
Duan J; Institute of Biomedical and Health Engineering, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.
Zhao Y; Institute of Biomedical and Health Engineering, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.
Sun Q; Institute of Biomedical and Health Engineering, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.
Liang D; Institute of Biomedical and Health Engineering, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.; The Key Laboratory of Biomedical Imaging Science and System, Chinese Academy of Sciences, Shenzhen, China.; National Innovation Center for Advanced Medical Devices, Shenzhen, China.; Shenzhen United Imaging Research Institute of Innovative Medical Equipment, Shenzhen, China.
Liu Z; Department of Radiology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.; Guangdong Provincial Key Laboratory of Artificial Intelligence in Medical Image Analysis and Application, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Chen X; Department of Radiology, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, China.
Li ZC; Institute of Biomedical and Health Engineering, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.; The Key Laboratory of Biomedical Imaging Science and System, Chinese Academy of Sciences, Shenzhen, China.; National Innovation Center for Advanced Medical Devices, Shenzhen, China.; Shenzhen United Imaging Research Institute of Innovative Medical Equipment, Shenzhen, China.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2023 Dec; Vol. 12 (23), pp. 21256-21269. Date of Electronic Publication: 2023 Nov 14.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Breast Neoplasms*/diagnostic imaging
Breast Neoplasms*/drug therapy
Breast Neoplasms*/genetics
Biological Products*/therapeutic use
Humans ; Female ; Breast/pathology ; Neoadjuvant Therapy/methods ; Proteomics ; Treatment Outcome ; Magnetic Resonance Imaging/methods ; Pathologic Complete Response ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Protooncogenic Role of ARHGAP11A and ARHGAP11B in Invasive Ductal Carcinoma: Two Promising Breast Cancer Biomarkers.
Autorzy:
Naeimzadeh Y; School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran.
Ilbeigi S; Walther-Straub Institute, Ludwig-Maximilians-Universität München, Munich, Germany.
Dastsooz H; Department of Life Sciences and Systems Biology, University of Turin, Turin, Italy.; Candiolo, C/o IRCCS, IIGM-Italian Institute for Genomic Medicine, Turin, Italy.; Candiolo Cancer (IT), FPO-IRCCS, Candiolo Cancer Institute, Turin, Italy.
Rafiee Monjezi M; Institute for Cardiovascular Prevention, Ludwig-Maximilians-Universität München, Munich, Germany.
Mansoori Y; Noncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran.
Tabei SMB; Department of Medical Genetics, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Pokaż więcej
Źródło:
BioMed research international [Biomed Res Int] 2023 Nov 23; Vol. 2023, pp. 8236853. Date of Electronic Publication: 2023 Nov 23 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Breast Neoplasms*/pathology
Carcinoma, Ductal, Breast*/pathology
Female ; Humans ; Biomarkers, Tumor/genetics ; Breast/pathology ; GTPase-Activating Proteins/genetics ; GTPase-Activating Proteins/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Evaluating the effectiveness of stain normalization techniques in automated grading of invasive ductal carcinoma histopathological images.
Autorzy:
Voon W; Department of Mechatronics and Biomedical Engineering, Faculty of Engineering and Science, Lee Kong Chian, Universiti Tunku Abdul Rahman, Kampar, Malaysia.
Hum YC; Department of Mechatronics and Biomedical Engineering, Faculty of Engineering and Science, Lee Kong Chian, Universiti Tunku Abdul Rahman, Kampar, Malaysia. .
Tee YK; Department of Mechatronics and Biomedical Engineering, Faculty of Engineering and Science, Lee Kong Chian, Universiti Tunku Abdul Rahman, Kampar, Malaysia.
Yap WS; Department of Electrical and Electronic Engineering, Faculty of Engineering and Science, Lee Kong Chian, Universiti Tunku Abdul Rahman, Kampar, Malaysia.
Nisar H; Department of Electronic Engineering, Faculty of Engineering and Green Technology, Universiti Tunku Abdul Rahman, 31900, Kampar, Malaysia.
Mokayed H; Department of Computer Science, Electrical and Space Engineering, Lulea University of Technology, Lulea, Sweden.
Gupta N; School of Electronics Engineering, Vellore Institute of Technology, Amaravati, AP, India.
Lai KW; Department of Biomedical Engineering, Universiti Malaya, 50603, Kuala Lumpur, Malaysia.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Nov 22; Vol. 13 (1), pp. 20518. Date of Electronic Publication: 2023 Nov 22.
Typ publikacji:
Journal Article
MeSH Terms:
Breast Neoplasms*/diagnostic imaging
Breast Neoplasms*/pathology
Carcinoma, Ductal*
Carcinoma, Ductal, Breast*/pathology
Humans ; Female ; Breast/pathology ; Neural Networks, Computer ; Staining and Labeling
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
3-D chromatin conformation, accessibility, and gene expression profiling of triple-negative breast cancer.
Autorzy:
Llinàs-Arias P; Cancer Epigenetics Laboratory at the Cancer Cell Biology Group, Health Research Institute of the Balearic Islands (IdISBa), 07120, Palma, Spain.
Ensenyat-Méndez M; Cancer Epigenetics Laboratory at the Cancer Cell Biology Group, Health Research Institute of the Balearic Islands (IdISBa), 07120, Palma, Spain.
Orozco JIJ; Saint John's Cancer Institute, Providence Saint John's Health Center, Santa Monica, CA, USA.
Íñiguez-Muñoz S; Cancer Epigenetics Laboratory at the Cancer Cell Biology Group, Health Research Institute of the Balearic Islands (IdISBa), 07120, Palma, Spain.
Valdez B; Saint John's Cancer Institute, Providence Saint John's Health Center, Santa Monica, CA, USA.
Wang C; Department of Biosciences and Nutrition, Science for Life Laboratory,, Karolinska Institutet, Stockholm, Sweden.
Mezger A; Science for Life Laboratory, Division of Gene Technology, KTH Royal Institute of Technology, Stockholm, Sweden.
Choi E; Science for Life Laboratory, Division of Gene Technology, KTH Royal Institute of Technology, Stockholm, Sweden.
Tran YZ; Department of Biosciences and Nutrition, Science for Life Laboratory,, Karolinska Institutet, Stockholm, Sweden.
Yao L; Department of Biosciences and Nutrition, Science for Life Laboratory,, Karolinska Institutet, Stockholm, Sweden.
Bonath F; Department of Biochemistry and Biophysics, Science for Life Laboratory, Stockholm University, Stockholm, Sweden.
Olsen RA; Department of Biochemistry and Biophysics, Science for Life Laboratory, Stockholm University, Stockholm, Sweden.
Ormestad M; Science for Life Laboratory, Division of Gene Technology, KTH Royal Institute of Technology, Stockholm, Sweden.
Esteller M; Josep Carreras Leukaemia Research Institute, Badalona, Barcelona, Catalonia, Spain.; Centro de Investigación Biomédica en Red Cancer (CIBERONC), 28029, Madrid, Spain.; Institució Catalana de Recerca I Estudis Avançats (ICREA), Barcelona, Catalonia, Spain.; Physiological Sciences Department, School of Medicine and Health Sciences, University of Barcelona (UB), Barcelona, Catalonia, Spain.
Lupien M; Princess Margaret Cancer Centre, Toronto, Toronto, ON, M5G 1L7, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, ON, M5G 1L7, Canada.; Ontario Institute for Cancer Research, Toronto, ON, M5G 0A3, Canada.
Marzese DM; Cancer Epigenetics Laboratory at the Cancer Cell Biology Group, Health Research Institute of the Balearic Islands (IdISBa), 07120, Palma, Spain. .
Pokaż więcej
Źródło:
BMC genomic data [BMC Genom Data] 2023 Nov 02; Vol. 24 (1), pp. 61. Date of Electronic Publication: 2023 Nov 02.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Triple Negative Breast Neoplasms*/genetics
Triple Negative Breast Neoplasms*/metabolism
Triple Negative Breast Neoplasms*/pathology
Humans ; Chromatin/genetics ; Cell Line, Tumor ; Gene Expression Profiling ; Breast/metabolism ; Breast/pathology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Aptamer-Based Recognition of Breast Tumor Cells: A New Era for Breast Cancer Diagnosis.
Autorzy:
de Araújo NS; Laboratório de Genômica Aplicada e Bioinovações, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro 21040-900, RJ, Brazil.
Moreira ADS; Laboratório de Genômica Aplicada e Bioinovações, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro 21040-900, RJ, Brazil.
Abreu RDS; Laboratório de Genômica Aplicada e Bioinovações, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro 21040-900, RJ, Brazil.
Junior VV; Laboratório de Genômica Aplicada e Bioinovações, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro 21040-900, RJ, Brazil.
Antunes D; Laboratório de Genômica Aplicada e Bioinovações, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro 21040-900, RJ, Brazil.
Mendonça JB; Laboratório de Genômica Aplicada e Bioinovações, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro 21040-900, RJ, Brazil.
Sassaro TF; Laboratório de Genômica Aplicada e Bioinovações, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro 21040-900, RJ, Brazil.
Jurberg AD; Laboratório de Pesquisas sobre o Timo, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro 21040-900, RJ, Brazil.; Laboratório de Animais Transgênicos, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro 21941-902, RJ, Brazil.; Instituto de Educação Médica (IDOMED), Universidade Estácio de Sá (UNESA)-Campus Vista Carioca, Rio de Janeiro 20071-004, RJ, Brazil.
Ferreira-Reis R; Laboratório de Pesquisas sobre o Timo, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro 21040-900, RJ, Brazil.
Bastos NC; Divisão de Patologia (DIPAT), Instituto Nacional do Câncer (INCA), Rio de Janeiro 20230-130, RJ, Brazil.
Fernandes PV; Divisão de Patologia (DIPAT), Instituto Nacional do Câncer (INCA), Rio de Janeiro 20230-130, RJ, Brazil.
Guimarães ACR; Laboratório de Genômica Aplicada e Bioinovações, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro 21040-900, RJ, Brazil.
Degrave WMS; Laboratório de Genômica Aplicada e Bioinovações, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro 21040-900, RJ, Brazil.
Tilli TM; Laboratório de Fisiopatologia Clínica e Experimental, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro 21040-900, RJ, Brazil.; Plataforma de Oncologia Translacional, Centro de Desenvolvimento Tecnológico em Saúde, Fiocruz, Rio de Janeiro 21040-900, RJ, Brazil.
Waghabi MC; Laboratório de Genômica Aplicada e Bioinovações, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro 21040-900, RJ, Brazil.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Jan 10; Vol. 25 (2). Date of Electronic Publication: 2024 Jan 10.
Typ publikacji:
Journal Article
MeSH Terms:
Breast Neoplasms*/diagnosis
Mammary Neoplasms, Animal*
Female ; Humans ; Animals ; Breast ; Cell Line, Tumor ; Oligonucleotides
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Prognostic nomograms for breast cancer with lung metastasis: a SEER-based population study.
Autorzy:
Xie Y; Department of Breast Surgery, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China.
Lei C; Department of Breast Surgery, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China.
Ma Y; Department of Breast Surgery, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China.
Li Y; Department of Breast Surgery, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China.
Yang M; Department of Breast Surgery, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China.
Zhang Y; Department of Breast Surgery, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China.
Law KN; Department of Breast Surgery, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China.
Wang N; Department of Breast Surgery, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China.
Qu S; Department of Breast Surgery, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China. .
Pokaż więcej
Źródło:
BMC women's health [BMC Womens Health] 2024 Jan 03; Vol. 24 (1), pp. 16. Date of Electronic Publication: 2024 Jan 03.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Breast Neoplasms*
Lung Neoplasms*/pathology
Female ; Humans ; Breast ; Neoplasm Staging ; Nomograms ; Prognosis ; Neoplasm Metastasis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
circ_0058063 promotes breast cancer progression by upregulating DLGAP5 via sponging miR-557.
Autorzy:
Zhu K; Department of Thyroid and Breast Surgery, Wuhan NO.1 Hospital, Wuhan, Hubei, China.; Department of Thyroid and Breast Surgery, Wuhan NO.1 Hospital, Wuhan, Hubei, China.
Yi C; Clinical Laboratory, Wuhan NO.1 Hospital, Wuhan, Hubei, China.; Department of Thyroid and Breast Surgery, Wuhan NO.1 Hospital, Wuhan, Hubei, China.
Tong C; Department of General Surgery, People's Hospital of Dongxihu District, Wuhan, Hubei, China.
Pokaż więcej
Źródło:
Cancer biomarkers : section A of Disease markers [Cancer Biomark] 2024; Vol. 39 (1), pp. 1-13.
Typ publikacji:
Journal Article
MeSH Terms:
Breast Neoplasms*/genetics
MicroRNAs*/genetics
Female ; Humans ; Apoptosis/genetics ; Blotting, Western ; Breast ; Cell Proliferation/genetics ; Neoplasm Proteins ; RNA, Circular/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The Role of the Toll-like Receptor 2 and the cGAS-STING Pathways in Breast Cancer: Friends or Foes?
Autorzy:
Cossu C; Department of Molecular Biotechnology and Health Sciences-Molecular Biotechnology Center 'Guido Tarone', University of Turin, Piazza Nizza 44, 10126 Turin, Italy.
Di Lorenzo A; Department of Molecular Biotechnology and Health Sciences-Molecular Biotechnology Center 'Guido Tarone', University of Turin, Piazza Nizza 44, 10126 Turin, Italy.
Fiorilla I; Department of Science and Technological Innovation (DISIT), University of Eastern Piedmont, 15121 Alessandria, Italy.
Todesco AM; Department of Science and Technological Innovation (DISIT), University of Eastern Piedmont, 15121 Alessandria, Italy.
Audrito V; Department of Science and Technological Innovation (DISIT), University of Eastern Piedmont, 15121 Alessandria, Italy.
Conti L; Department of Molecular Biotechnology and Health Sciences-Molecular Biotechnology Center 'Guido Tarone', University of Turin, Piazza Nizza 44, 10126 Turin, Italy.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Dec 29; Vol. 25 (1). Date of Electronic Publication: 2023 Dec 29.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Breast Neoplasms*
Humans ; Female ; Toll-Like Receptor 2 ; Breast ; Drug Development ; Nucleotidyltransferases ; Tumor Microenvironment
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Incidental Bystander or Essential Culprit: A Systematic Review of Bacterial Significance in the Pathogenesis of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Autorzy:
Foppiani JA; Division of Plastic Surgery, Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.; Institute of Pathological Physiology, First Faculty of Medicine, Charles University, 12108 Prague, Czech Republic.
Raska O; Institute of Pathological Physiology, First Faculty of Medicine, Charles University, 12108 Prague, Czech Republic.
Taritsa I; Division of Plastic Surgery, Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
Hernandez Alvarez A; Division of Plastic Surgery, Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
Lee D; Division of Plastic Surgery, Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
Escobar-Domingo MJ; Division of Plastic Surgery, Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
Berger J; Eberhard Karl University of Tübingen, 72076 Tübingen, Germany.
Klener P; Institute of Pathological Physiology, First Faculty of Medicine, Charles University, 12108 Prague, Czech Republic.; First Department of Internal Medicine, Department of Hematology, First Faculty of Medicine Charles University, General University Hospital, 12808 Prague, Czech Republic.
Schuster KA; Division of Plastic Surgery, Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
Abdo D; Institute of Pathological Physiology, First Faculty of Medicine, Charles University, 12108 Prague, Czech Republic.
Clemens MW; MD Anderson Cancer Center, The University of Texas, Houston, TX 77030, USA.
Lin SJ; Division of Plastic Surgery, Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Dec 26; Vol. 25 (1). Date of Electronic Publication: 2023 Dec 26.
Typ publikacji:
Systematic Review; Journal Article; Review
MeSH Terms:
Breast Implants*/adverse effects
Lymphoma, Large-Cell, Anaplastic*/etiology
Humans ; Female ; Proteomics ; Breast ; Bacteria
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
miRNA-378 Is Downregulated by XBP1 and Inhibits Growth and Migration of Luminal Breast Cancer Cells.
Autorzy:
Arabkari V; Discipline of Pathology, Cancer Progression and Treatment Research Group, Lambe Institute for Translational Research, School of Medicine, University of Galway, H91TK33 Galway, Ireland.; Krefting Research Centre, Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, University of Gothenburg, 40530 Gothenburg, Sweden.
Barua D; Discipline of Pathology, Cancer Progression and Treatment Research Group, Lambe Institute for Translational Research, School of Medicine, University of Galway, H91TK33 Galway, Ireland.
Hossain MM; Discipline of Pathology, Cancer Progression and Treatment Research Group, Lambe Institute for Translational Research, School of Medicine, University of Galway, H91TK33 Galway, Ireland.; Department of Biochemistry and Molecular Biology, University of Chittagong, Chittagong 4331, Bangladesh.
Webber M; Discipline of Pathology, Cancer Progression and Treatment Research Group, Lambe Institute for Translational Research, School of Medicine, University of Galway, H91TK33 Galway, Ireland.
Smith T; Molecular Diagnostic Research Group, College of Science, University of Galway, H91TK33 Galway, Ireland.
Gupta A; Discipline of Physiology, School of Medicine, University of Galway, H91TK33 Galway, Ireland.
Gupta S; Discipline of Pathology, Cancer Progression and Treatment Research Group, Lambe Institute for Translational Research, School of Medicine, University of Galway, H91TK33 Galway, Ireland.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Dec 22; Vol. 25 (1). Date of Electronic Publication: 2023 Dec 22.
Typ publikacji:
Journal Article
MeSH Terms:
Breast Neoplasms*/genetics
MicroRNAs*/genetics
Humans ; Female ; X-Box Binding Protein 1/genetics ; Cell Proliferation/genetics ; Breast ; RNA-Binding Proteins
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Identification of MicroRNAs Associated with Histological Grade in Early-Stage Invasive Breast Cancer.
Autorzy:
Kurozumi S; Department of Breast Surgery, International University of Health and Welfare, Chiba 286-8520, Japan.; Department of General Surgical Science, Gunma University Graduate School of Medicine, Gunma 371-8511, Japan.
Seki N; Department of Functional Genomics, Chiba University Graduate School of Medicine, Chiba 260-8670, Japan.
Narusawa E; Department of General Surgical Science, Gunma University Graduate School of Medicine, Gunma 371-8511, Japan.
Honda C; Department of General Surgical Science, Gunma University Graduate School of Medicine, Gunma 371-8511, Japan.
Tokuda S; Department of General Surgical Science, Gunma University Graduate School of Medicine, Gunma 371-8511, Japan.
Nakazawa Y; Department of General Surgical Science, Gunma University Graduate School of Medicine, Gunma 371-8511, Japan.
Yokobori T; Initiative for Advanced Research, Gunma University, Gunma 371-8511, Japan.
Katayama A; Department of Diagnostic Pathology, Gunma University Graduate School of Medicine, Gunma 371-8511, Japan.
Mongan NP; Biodiscovery Institute, Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham NG7 2RD, UK.
Rakha EA; Academic Unit for Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham NG7 2RD, UK.; Pathology Department, Hamad Medical Corporation, Doha P.O. Box 3050, Qatar.
Oyama T; Department of Diagnostic Pathology, Gunma University Graduate School of Medicine, Gunma 371-8511, Japan.
Fujii T; Department of General Surgical Science, Gunma University Graduate School of Medicine, Gunma 371-8511, Japan.
Shirabe K; Department of General Surgical Science, Gunma University Graduate School of Medicine, Gunma 371-8511, Japan.
Horiguchi J; Department of Breast Surgery, International University of Health and Welfare, Chiba 286-8520, Japan.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Dec 19; Vol. 25 (1). Date of Electronic Publication: 2023 Dec 19.
Typ publikacji:
Journal Article
MeSH Terms:
MicroRNAs*/genetics
Breast Neoplasms*/genetics
Humans ; Female ; Breast ; Cluster Analysis ; Computational Biology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 41-60 z 890170

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies